Inactive Instrument

Insiders Mirati Therapeutics

Equities

Mirati Therapeutics, Inc. Announces Management Changes	Jan. 23	CI
Immunome Appoints Phil Roberts as Chief Technical Officer	Jan. 04	MT
Mirati Therapeutics CFO Laurie Stelzer to Depart; Aaron Ondrey Named Interim CFO	23-08-23	MT
Insider Buy: Mirati Therapeutics	23-08-14	MT
Mirati Therapeutics Appoints Carol Gallagher, Pharm.D. as New Independent Director	23-06-23	CI
Insider Sell: Mirati Therapeutics	23-06-05	MT
Insider Sell: Mirati Therapeutics	23-01-20	MT
Insider Sell: Mirati Therapeutics	23-01-19	MT
Insider Sell: Mirati Therapeutics	23-01-05	MT
Insider Sell: Mirati Therapeutics	22-12-20	MT
Fed Meeting Eyed as Exchange-Traded Funds, Stock Futures Gain Pre-Bell Tuesday	22-12-13	MT
Insider Sell: Mirati Therapeutics	22-12-05	MT
Insider Sell: Mirati Therapeutics	22-11-29	MT
Mirati Therapeutics, Inc. Announces Management Changes	22-11-08	CI
Insider Sell: Mirati Therapeutics	22-08-16	MT
Insider Buy: Gossamer Bio	22-07-15	MT
Mirati Therapeutics Appoints Laurie Stelzer CFO	22-05-16	MT
Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer	22-05-16	CI
Insider Sell: Gossamer Bio	22-03-24	MT
AnaptysBio Taps Former Mirati Therapeutics' COO as Interim CEO	22-03-21	MT

No results for this search